Literature DB >> 20115946

Alopecia areata update: part II. Treatment.

Abdullah Alkhalifah1, Adel Alsantali, Eddy Wang, Kevin J McElwee, Jerry Shapiro.   

Abstract

UNLABELLED: Various therapeutic agents have been described for the treatment of alopecia areata (AA), but none are curative or preventive. The aim of AA treatment is to suppress the activity of the disease. The high rate of spontaneous remission and the paucity of randomized, double-blind, placebo-controlled studies make the evidence-based assessment of these therapies difficult. The second part of this two-part series on AA discusses treatment options in detail and suggests treatment plans according to specific disease presentation. It also reviews recently reported experimental treatment options and potential directions for future disease management. LEARNING
OBJECTIVES: After completing this learning activity, participants should be able to compare the efficacy and safety of various treatment options, formulate a treatment plan tailored to individual patients, and recognize recently described treatments and potential therapeutic approaches. Copyright (c) 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20115946     DOI: 10.1016/j.jaad.2009.10.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  51 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

Review 2.  The Role of Micronutrients in Alopecia Areata: A Review.

Authors:  Jordan M Thompson; Mehwish A Mirza; Min Kyung Park; Abrar A Qureshi; Eunyoung Cho
Journal:  Am J Clin Dermatol       Date:  2017-10       Impact factor: 7.403

3.  Trichoscopy of Steroid-Induced Atrophy.

Authors:  Rodrigo Pirmez; Leonardo S Abraham; Bruna Duque-Estrada; Patrícia Damasco; Débora Cadore Farias; Yanna Kelly; Isabella Doche
Journal:  Skin Appendage Disord       Date:  2017-04-28

4.  Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Alexandra C Villasante; Lucia M Mauro; Carmen I Perez; Lawrence A Schachner; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2011-11-01       Impact factor: 3.667

Review 5.  Alopecia Areata: An Update on Treatment Options for Children.

Authors:  Lauren Peloquin; Leslie Castelo-Soccio
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

6.  Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.

Authors:  Julian Mackay-Wiggan; Ali Jabbari; Nhan Nguyen; Jane E Cerise; Charlotte Clark; Grace Ulerio; Megan Furniss; Roger Vaughan; Angela M Christiano; Raphael Clynes
Journal:  JCI Insight       Date:  2016-09-22

7.  Intralesional steroids for alopecia areata.

Authors:  M Kumaresan
Journal:  Int J Trichology       Date:  2010-01

8.  Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.

Authors:  Yin-Ku Lin; Saleh A Al-Suwayeh; Yann-Lii Leu; Feng-Ming Shen; Jia-You Fang
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

9.  Corticosteroids for alopecia areata in children.

Authors:  Tharindu Fernando; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-07       Impact factor: 3.275

10.  Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.

Authors:  Ibrahim A Aljuffali; Calvin T Sung; Feng-Ming Shen; Chi-Ting Huang; Jia-You Fang
Journal:  AAPS J       Date:  2013-12-04       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.